GOIL PLC recorded a robust performance in 2024 financial year, recording a year-on-year profit of GH¢84.7 million, a 54.82 per cent growth over...

The leading 30 pharmaceutical companies, with revenues above Rs 2,500 crore, have registered robust net profit growth of 31 per cent during the...

The leading 30 pharmaceutical companies, with revenues above Rs 2,500 crore, have registered robust net profit growth of 31 per cent during the...

According to a study by Pharmabiz, the leading 30 pharmaceutical companies, with revenues above Rs. 2,500 crore, have registered a robust net profit...

According to a study by Pharmabiz, the leading 30 pharmaceutical companies, with revenues above Rs. 2,500 crore, have registered a robust net profit...

In year-on-year terms, interest income improved to GH¢13.9 billion, up from GH¢12.0 billion, suggesting a modest growth of 15.9% relative to 19.4%...

In year-on-year terms, interest income improved to GH¢13.9 billion, up from GH¢12.0 billion, suggesting a modest growth of 15.9% relative to 19.4%...

 L-R: Independent Non-Executive Director, Dangote Cement Plc, Emmanuel Ikazoboh; Chairman, Dangote Cement Plc, Aliko Dangote; Group Managing...

The country’s year-on-year producer price inflation in May 2025 fell to 10.2 per cent from 18.5 per cent in April. This represents a decline of 8.3...

The robust performance has reversed the current account deficit of $11.3 billion (1.1 per cent of GDP) in the preceding third quarter...